FiercePharma  Jun 20  Comment 
Following a daylong meeting on Tuesday, an FDA expert panel voted to recommend a label update for Novo’s blockbuster diabetes drug Victoza stating the med can lower cardiovascular risks for high-risk Type 2 diabetes patients.
FierceBiotech  Jun 20  Comment 
EvaluatePharma says spending on global pharma research will hit $181 billion in five years as Roche, AbbVie and AstraZeneca are seen as having some of the biggest potential pipeline meds.
FiercePharma  Jun 15  Comment 
Just a few days after unveiling new cardiovascular data for long-acting insulin Tresiba, Novo Nordisk has made moves to get them added to the medication’s label.
FiercePharma  Jun 12  Comment 
Competing with Sanofi blockbuster Lantus is no easy task, but that's exactly what Novo Nordisk's long-acting insulin Tresiba has to do. Thanks to new data, though, the drugmaker can safely say its newcomer poses no increased heart risks—and it...

You may also be interested in articles related to Novo Nordisk A/S (NVO):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki